|

MK-2828 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1

Indications

  • Diabetes1
  • Diabetes Mellitus, Type 21

Chula Vista, California1 trial

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

ProSciento Inc. ( Site 0004)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.